Option Care Health to buy Amedisys for $3.6B

Option Care Health, the nation’s largest independent provider of home and alternate site infusion services, is buying Amedisys, a leading home health, hospice and high-acuity care provider, for $3.6 billion.

Advertisement

The merger will “create a leading, independent platform for home and alternate site care,” according to a May 3 news release from Option. Together, the companies have a clinical workforce of more than 16,500 professionals across 674 care centers.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Post-Acute

Advertisement

Comments are closed.